Long-term efficacy of rituximab in chronic ataxic neuropathy associated with anti-ganglioside antibodies

Bertran-Recasens, BernatFigueras-Aguirre, GeorginaRoyo de Mingo, I.Rubio Pérez, Miguel Angel2022-06-272022-06-272021Bertran Recasens B, Figueras-Aguirre G, Royo De Mingo I, Rubio MÁ. Long-term efficacy of rituximab in chronic ataxic neuropathy associated with anti-ganglioside antibodies. Neurologia (Engl Ed). 2021 Nov-Dec;36(9):739-42. DOI: 10.1016/j.nrleng.2021.02.0062173-5808http://hdl.handle.net/10230/53589application/pdfeng© 2021 Published by Elsevier España, S.L.U. on behalf of Sociedad Española de Neurología. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Long-term efficacy of rituximab in chronic ataxic neuropathy associated with anti-ganglioside antibodiesEficacia a largo plazo del rituximab en la neuropatía crónica atáxica con anticuerpos antigangliósidosinfo:eu-repo/semantics/articlehttp://dx.doi.org/10.1016/j.nrleng.2021.02.006info:eu-repo/semantics/openAccess